Shinichi Oka , Tomohiro Yamaki, Masanori Sasaki, Ryo Ukai , Mitsuhiro Takemura , Takahiro Yokoyama , Yuko Kataoka-Sasaki, Rie Onodera , Yoichi M Ito , Shigeki Kobayashi , Jeffery D Kocsis , Yasuo Iwadate , Osamu Honmou Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial JMIR Res Protoc. 2022 Jul 6;11(7):e37898.

Mari Maeda-Yamamoto , Osamu Honmou , Masanori Sasaki , Akane Haseda , Hiroyo Kagami-Katsuyama , Toshihiko Shoji , Ai Namioka , Takahiro Namioka , Hirotoshi Magota , Shinichi Oka , Yuko Kataoka-Sasaki , Ryou Ukai , Mitsuhiro Takemura , Jun Nishihira The Impact of Purple-Flesh Potato ( Solanum tuberosum L.) cv. "Shadow Queen" on Minor Health Complaints in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study Nutrients. 2022 Jun 13;14(12):2446.

Ryosuke Hirota, Masanori Sasaki, Yuko Kataoka-Sasaki, Tsutomu Oshigiri, Kota Kurihara, Ryunosuke Fukushi, Shinichi Oka, Ryo Ukai, Mitsunori Yoshimoto, Jeffery D Kocsis, Toshihiko Yamashita, Osamu Honmou Enhanced network in corticospinal tracts after infused mesenchymal stem cells in spinal cord injury J Neurotrauma. 2022 May 25.

Masahito Nakazaki, Shinichi Oka, Hirotoshi Magota, Ryo Kiyose, Rie Onodera, Ryo Ukai, Yuko Kataoka-Sasaki, Masanori Sasaki, Osamu Honmou Pharmacological Difference Between Platelet Aggregations in Cardioembolic Stroke Patients with Direct Oral Anticoagulants: A Pilot Study J Stroke Cerebrovasc Dis. 2022 May 3;31(7):106520.

Mitsuhiro Takemura, Masanori Sasaki, Yuko Kataoka-Sasaki, Ryo Kiyose, Hiroshi Nagahama, Shinichi Oka, Ryo Ukai, Takahiro Yokoyama, Jeffery D. Kocsis, Tetsuya Ueba, Osamu Honmou Repeated intravenous infusion of mesenchymal stem cells for enhanced functional recovery in a rat model of chronic cerebral ischemia J Neurosurg. 2021 Dec 3;1-10.

Hidetoshi Tabata, Masanori Sasaki, Yuko Kataoka-Sasaki, Nobuo Shinkai, Koji Ichihara, Naoya Masumori, Jeffery D. Kocsis, Osamu Honmou Possible role of intravenous administration of mesenchymal stem cells to alleviate interstitial cystitis/bladder pain syndrome in a Toll-like receptor-7 agonist-induced experimental animal model in rat BMC Urol. 2021 Nov 13;21(1):156.

Tsugufumi Nakagawa, Masanori Sasaki, Yuko Kataoka-Sasaki, Takatoshi Yotsuyanagi, Christine Radtke, Jeffery D. Kocsis, Osamu Honmou Intravenous Infusion of Mesenchymal Stem Cells Promotes the Survival of Random Pattern Flaps in Rats Plast Reconstr Surg. 2021 Oct 1;148(4):799-807.

Hirotoshi Magota, Masanori Sasaki, Yuko Kataoka-Sasaki, Shinichi Oka, Ryo Ukai, Ryo Kiyose, Rie Onodera, Jeffery D Kocsis, Osamu Honmou Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis Mol Brain. 2021 May 7;14(1):76.

Honmou O, Yamashita T, Morita T, Oshigiri T, Hirota R, Iyama S, Kato J, Sasaki Y, Ishiai S, Ito YM, Namioka A, Namioka T, Nakazaki M, Kataoka-Sasaki Y, Onodera R, Oka S, Sasaki M, Waxman SG, Kocsis JD. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series. Clin Neurol Neurosurg. 2021 Apr;203:106565.

Ryo Kiyose, Masanori Sasaki, Yuko Kataoka-Sasaki, Masahito Nakazaki, Hiroshi Nagahama, Hirotoshi Magota, Shinichi Oka, Ryo Ukai, Mitsuhiro Takemura, Takahiro Yokoyama, Jeffery D Kocsis, Osamu Honmou Intravenous infusion of mesenchymal stem cells enhances therapeutic efficacy of reperfusion therapy in cerebral ischemia World Neurosurg. 2021 Feb 19;S1878-8750

Ai Namioka, Takahiro Namioka, Masanori Sasaki, Jeffery D Kocsis, Osamu Honmou Focal brainstem infarction in the adult rat
Lab Anim (NY) 2021 Feb 9

Hirotoshi Magota, Masanori Sasaki, Yuko Kataoka-Sasaki, Shinichi Oka, Ryo Ukai, Ryo Kiyose, Rie Onodera, Jeffery D Kocsis, Osamu Honmou Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model Brain Res 2021 Jan 28;147296.

Masahito Nakazaki, Shinichi Oka, Masanori Sasaki, Yuko Kataoka-Sasaki, Hiroshi Nagahama, Kazuo Hashi, Jeffery D Kocsis, Osamu Honmou Prolonged lifespan in a spontaneously hypertensive rat (stroke prone) model following intravenous infusion of mesenchymal stem cells Heliyon 2020 Dec 25;6(12)

Yasuda N, Sasaki M, Kataoka-Sasaki Y, Nagahama H, Kocsis JD, Kawaharada N, Honmou O. Intravenous delivery of mesenchymal stem cells protects both white and gray matter in spinal cord ischemia. Brain Res. 2020 Aug 6;1747:147040.

Sasaki M, Oka S, Kataoka-Sasaki Y, Kocsis JD, Honmou O. "Chronic" State in Neural Diseases as the Target of Cellular Therapy with Mesenchymal Stem Cells. World Neurosurg. 2020 Mar;135:375-376.

Nakazaki M, Oka S, Sasaki M, Kataoka-Sasaki Y, Onodera R, Komatsu K, Iihoshi S, Hiroura M, Kawaguchi A, Kocsis JD, Honmou O. Prevention of neointimal hyperplasia induced by an endovascular stent via intravenousinfusion of mesenchymal J Neurosurg. 2019 Oct 4:1-13.

Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Oka S, Suzuki J, Sasaki Y, Nagahama H, Hashi K, Kocsis JD, Honmou O. Intravenous infusion of mesenchymal stem cells improves impaired cognitive function in a cerebral small vessel disease model. Neuroscience. 2019 Apr 16. pii: S0306-4522(19)30258-1. doi: 10.1016/j.neuroscience.2019.04.018.

Namioka A, Namioka T, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Kocsis JD, Honmou O. Intravenous infusion of mesenchymal stem cells for protection against brainstem infarction in a persistent basilar artery occlusion model in the adult rat. J Neurosurg. 2018 Oct 1:1-9.

Namioka T, Namioka A, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Kocsis JD, Honmou O. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction. J Neurosurg. 2018 Oct 1:1-8.

Sakai T, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Fukumura S, Kobayashi M, Tsutsumi H, Kocsis JD, Honmou O. Functional recovery after the systemic administration of mesenchymal stem cells in a rat model of neonatal hypoxia-ischemia. J Neurosurg Pediatr. 2018 Aug 3:1-10.

Wanibuchi M, Ohtaki S, Ookawa S, Kataoka-Sasaki Y, Sasaki M, Oka S, Kimura Y, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O. Actin, alpha, cardiac muscle 1 (ACTC1) knockdown inhibits the migration of glioblastoma cells in vitro. J Neurol Sci. 2018 Jul 17;392:117-121.

Oshigiri T, Sasaki T, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Oka S, Morita T, Hirota R, Yoshimoto M, Yamashita T, Hashimoto-Torii K, Honmou O. Intravenous Infusion of Mesenchymal Stem Cells Alters Motor Cortex Gene Expression in a Rat Model of Acute Spinal Cord Injury. J Neurotrauma. 2018 Jun 14.

Nagahama H, Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Namioka T, Namioka A, Oka S, Onodera R, Suzuki J, Sasaki Y, Kocsis JD, Honmou O. Preservation of interhemispheric cortical connections through corpus callosum following intravenous infusion of mesenchymal stem cells in a rat model of cerebral infarction. Brain Res. 2018 Sep 15;1695:37-44.

Houkin K, Shichinohe H, Abe K, Arato T, Dezawa M, Honmou O, Horie N, Katayama Y, Kudo K, Kuroda S, Matsuyama T, Miyai I, Nagata I, Niizuma K, Sakushima K, Sasaki M, Sato N, Sawanobori K, Suda S, Taguchi A, Tominaga T, Yamamoto H, Yamashita T, Yoshimine T; Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction. Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products. Stroke. 2018 Apr;49(4):e145-e152.

Fukumura S, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Nagahama H, Morita T, Sakai T, Tsutsumi H, Kocsis JD, Honmou O. Intravenous infusion of mesenchymal stem cells reduces epileptogenesis in a rat model of status epilepticus. Epilepsy Res. 2018 Mar;141:56-63.

Ookawa S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Ohtaki S, Noshiro S, Komatsu K, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O. Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma. World Neurosurg. 2018 Mar;111:e783-e789.

Matsuda Y, Sasaki M, Kataoka-Sasaki Y, Takayanagi A, Kobayashi K, Oka S, Nakazaki M, Masumori N, Kocsis JD, Honmou O. Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Erectile Dysfunction Following Cavernous Nerve Injury in Rats. Sex Med. 2018 Mar;6(1):49-57.

Nakazaki M, Nonaka T, Nomura T, Onda T, Yonemasu Y, Takahashi A, Hashimoto Y, Honda O, Oka S, Sasaki M, Daibo M, Honmou O. Cerebral aneurysm neck diameter is an independent predictor of progressive occlusion after stent-assisted coiling. Acta Neurochir (Wien). 2017 Jul;159(7):1313-1319.

Nakamura H, Sasaki Y, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Namioka T, Namioka A, Onodera R, Suzuki J, Nagahama H, Mikami T, Wanibuchi M, Kocsis JD, Honmou O. Elevated brain derived neurotrophic factor (BDNF) levels in plasma but not serum reflect in vivo functional viability of infused mesenchymal stem cells after middle cerebral artery occlusion in rat. J Neurosurg Sci. 2017 Feb 8.

Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Ohnishi H, Ohtaki S, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O. Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations. J Clin Neurosci. 2017 Mar;37:83-90.

Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Otsuka Y, Yamaguchi M, Ohnishi H, Ohtaki S, Noshiro S, Ookawa S, Mikami T, Mikuni N, Honmou O. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas. J Neurosurg Sci. 2018 Jun;62(3):239-244.

Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Oka S, Namioka T, Namioka A, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Mikami T, Wanibuchi M, Kocsis JD, Honmou O. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats. J Neurosurg. 2017 Oct;127(4):917-926.

Morita T, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Oka S, Oshigiri T, Takebayashi T, Yamashita T, Kocsis JD, Honmou O. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience. 2016 Aug 30. [Epub ahead of print]

Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Hashi K, Ohtaki S, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O., Biological relevance of tissue factor and IL-6 in arteriovenous malformations. Neurosurg Rev. 2016 Aug 19. [Epub ahead of print]

Sasaki Y, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Suzuki J, Tateyama D, Oka S, Namioka T, Namioka A, Onodera R, Mikami T, Wanibuchi M, Kakizawa M, Ishiai S, Kocsis JD, Honmou O. Synergic Effects of Rehabilitation and Intravenous Infusion of Mesenchymal Stem Cells After Stroke in Rats. Phys Ther. 2016 May 12. [Epub ahead of print]

Nakazaki M, Nonaka T, Takahashi A, Yonemasu Y, Nomura T, Onda T, Honda O, Hashimoto Y, Ohnishi H, Sasaki M, Daibo M, Honmou O. Double balloon protection during carotid artery stenting for vulnerable carotid stenosis reduces the incidence of new brain lesions. Acta Neurochir (Wien). 2016 May 2. [Epub ahead of print]

Ohtaki S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Noshiro S, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O. ACTC1 as an invasion and prognosis marker in glioma. J Neurosurg. 2016 Apr 15:1-9. [Epub ahead of print]

Takayanagi A, Sasaki M, Kataoka-Sasaki Y, Kobayashi K, Matsuda Y, Oka S, Masumori N, Kocsis JD, Honmou O. Intravenous Preload of Mesenchymal Stem Cells Rescues Erectile Function in a Rat Model of Cavernous Nerve Injury. J Sex Med. 12 (2015): 713-21.

Matsushita T, Lankford KL, Arroyo EJ, Sasaki M, Neyazi M, Radtke C, Kocsis JD. Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells. Exp Neurol. 267 (2015) :152-64.

Suzuki S, Kawamata J, Iwahara N, Matsumura A, Hisahara S, Matsushita T, Sasaki M, Honmou O, Shimohama S. Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats. Neurosci Lett. 2015 Jan 1;584:276-81.

Lankford KL, Brown RJ, Sasaki M, Kocsis JD.
Olfactory ensheathing cells, but not Schwann cells, proliferate and migrate extensively within moderately X-irradiated juvenile rat brain.
Glia. 62 (2014) : 52-63.

Suzuki J, Sasaki M, Harada K, Bando M, Kataoka Y, Onodera R, Mikami T, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O.
Bilateral Cortical Hyperactivity Detected by fMRI Associates with Improved Motor Function Following Intravenous Infusion of Mesenchymal Stem Cells in a Rat Stroke Model,
Brain Research 1497 (2013) 15-22

Kocsis JD, Honmou O.
Bone marrow stem cells in experimental stroke.
Prog Brain Res. 2012;201:79-98. doi: 10.1016/B978-0-444-59544-7.00005-6.

Inden M, Takata K, Nishimura K, Kitamura Y, Ashihara E, Yoshimoto K, Ariga H, Honmou O, Shimohama S.
Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice.
J Neurosci Res. 2013 Jan;91(1):62-72. doi: 10.1002/jnr.23128. Epub 2012 Oct 17.
PMID: 23073839 [PubMed - in process]

Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD.
Mesenchymal stem cells:therapeutic outlook for stroke. Trends Mol Med. 2012 Mar 27.
[Epub ahead of print] PubMed PMID: 22459358.

Sasaki Y, Honmou O. [Bone marrow stem cell therapy for stroke]. Nihon Rinsho.
2011 Dec;69(12):2203-8. Japanese. PubMed PMID: 22242320.

Radtke C, Sasaki M, Lankford KL, Gallo V, Kocsis JD. CNPase expression in
olfactory ensheathing cells. J Biomed Biotechnol. 2011;2011:608496. Epub 2011 Nov
16. PubMed PMID: 22174557; PubMed Central PMCID: PMC3228405.

Katada R, Nishitani Y, Honmou O, Mizuo K, Okazaki S, Tateda K, Watanabe S,
Matsumoto H. Expression of aquaporin-4 augments cytotoxic brain edema after
traumatic brain injury during acute ethanol exposure. Am J Pathol. 2012
Jan;180(1):17-23. Epub 2011 Nov 1. PubMed PMID: 22051773.

Sasaki M, Honmou O, Radtke C, Kocsis JD.
Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.
PLoS One. 2011;6(10):e26577. Epub 2011 Oct 24. PubMed PMID: 22039510; PubMed Central PMCID: PMC3200343.

Song CH, Honmou O, Furuoka H, Horiuchi M. Identification of chemoattractive
factors involved in the migration of bone marrow-derived mesenchymal stem cells
to brain lesions caused by prions. J Virol. 2011 Nov;85(21):11069-78. Epub 2011
Aug 3. PubMed PMID: 21813601; PubMed Central PMCID: PMC3194951.

Matsushita T, Kibayashi T, Katayama T, Yamashita Y, Suzuki S, Kawamata J,
Honmou O, Minami M, Shimohama S. Mesenchymal stem cells transmigrate across brain
microvascular endothelial cell monolayers through transiently formed
inter-endothelial gaps. Neurosci Lett. 2011 Sep 8;502(1):41-5. Epub 2011 Jul 20.
PubMed PMID: 21798315.

Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, Waxman SG,
Kocsis JD. Intravenous administration of auto serum-expanded autologous
mesenchymal stem cells in stroke. Brain. 2011 Jun;134(Pt 6):1790-807. Epub 2011
Apr 14. PubMed PMID: 21493695; PubMed Central PMCID: PMC3102237.

Sasaki M, Lankford KL, Radtke C, Honmou O, Kocsis JD. Remyelination after
olfactory ensheathing cell transplantation into diverse demyelinating
environments. Exp Neurol. 2011 May;229(1):88-98. Epub 2011 Jan 28. Review. PubMed
PMID: 21281634.

Sasaki M, Lankford KL, Brown RJ, Ruddle NH, Kocsis JD. Focal experimental
autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin
oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial
growth factor. Glia. 2010 Oct;58(13):1523-31. PubMed PMID: 20645414.

Honmou O, Houkin K. [Stem cell therapy for cerebral ischemia]. No Shinkei
Geka. 2010 Jun;38(6):515-20. Review. Japanese. PubMed PMID: 20543224.

Onodera R, Teramukai S, Tanaka S, Kojima S, Horie T, Matoba S, Murohara T,
Matsubara H, Fukushima M; BMMNC Follow-Up Study Investigators; M-PBMNC Follow-Up
Study Investigators. Bone marrow mononuclear cells versus G-CSF-mobilized
peripheral blood mononuclear cells for treatment of lower limb ASO: pooled
analysis for long-term prognosis. Bone Marrow Transplant. 2011 Feb;46(2):278-84.
Epub 2010 May 17. PubMed PMID: 20479708.

Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, Kocsis JD.
Intravenous administration of mesenchymal stem cells derived from bone marrow
after contusive spinal cord injury improves functional outcome. Brain Res. 2010
Jul 9;1343:226-35. Epub 2010 May 12. PubMed PMID: 20470759.

Komatsu K, Honmou O, Suzuki J, Houkin K, Hamada H, Kocsis JD. Therapeutic
time window of mesenchymal stem cells derived from bone marrow after cerebral
ischemia. Brain Res. 2010 Jun 2;1334:84-92. Epub 2010 Apr 9. PubMed PMID:
20382136.

Kataoka Y, Kalanithi PS, Grantz H, Schwartz ML, Saper C, Leckman JF,
Vaccarino FM. Decreased number of parvalbumin and cholinergic interneurons in the
striatum of individuals with Tourette syndrome. J Comp Neurol. 2010 Feb
1;518(3):277-91. PubMed PMID: 19941350; PubMed Central PMCID: PMC2846837.

Sasaki M, Radtke C, Tan AM, Zhao P, Hamada H, Houkin K, Honmou O, Kocsis JD.
BDNF-hypersecreting human mesenchymal stem cells promote functional recovery,
axonal sprouting, and protection of corticospinal neurons after spinal cord
injury. J Neurosci. 2009 Nov 25;29(47):14932-41. PubMed PMID: 19940189; PubMed
Central PMCID: PMC2825276.

Zheng W, Honmou O, Miyata K, Harada K, Suzuki J, Liu H, Houkin K, Hamada H,
Kocsis JD. Therapeutic benefits of human mesenchymal stem cells derived from bone
marrow after global cerebral ischemia. Brain Res. 2010 Jan 15;1310:8-16. Epub
2009 Nov 12. PubMed PMID: 19913518.

Markakis EA, Sasaki M, Lankford KL, Kocsis JD. Convergence of cells from the
progenitor fraction of adult olfactory bulb tissue to remyelinating glia in
demyelinating spinal cord lesions. PLoS One. 2009 Sep 29;4(9):e7260. PubMed PMID:
19787061; PubMed Central PMCID: PMC2747269.

Horie T, Onodera R, Akamastu M, Ichikawa Y, Hoshino J, Kaneko E, Iwashita C,
Ishida A, Tsukamoto T, Teramukai S, Fukushima M, Kawamura A; Japan Study Group of
Peripheral Vascular Regeneration Cell Therapy (JPRCT). Long-term clinical
outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized
autologous peripheral blood mononuclear cells. Atherosclerosis. 2010
Feb;208(2):461-6. Epub 2009 Aug 3. PubMed PMID: 19720375.

Kawamoto A, Katayama M, Handa N, Kinoshita M, Takano H, Horii M, Sadamoto K,
Yokoyama A, Yamanaka T, Onodera R, Kuroda A, Baba R, Kaneko Y, Tsukie T, Kurimoto
Y, Okada Y, Kihara Y, Morioka S, Fukushima M, Asahara T. Intramuscular
transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb
ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical
trial. Stem Cells. 2009 Nov;27(11):2857-64. PubMed PMID: 19711453.

Katada R, Nishitani Y, Honmou O, Okazaki S, Houkin K, Matsumoto H. Prior
ethanol injection promotes brain edema after traumatic brain injury. J
Neurotrauma. 2009 Nov;26(11):2015-25. PubMed PMID: 19558208.

Kocsis JD, Lankford KL, Sasaki M, Radtke C. Unique in vivo properties of
olfactory ensheathing cells that may contribute to neural repair and protection
following spinal cord injury. Neurosci Lett. 2009 Jun 12;456(3):137-42. Epub 2009
Jan 17. Review. PubMed PMID: 19429149; PubMed Central PMCID: PMC2713444.

Sasaki M, Honmou O, Kocsis JD. A rat middle cerebral artery occlusion model
and intravenous cellular delivery. Methods Mol Biol. 2009;549:187-95. PubMed
PMID: 19378204.

Song CH, Honmou O, Ohsawa N, Nakamura K, Hamada H, Furuoka H, Hasebe R,
Horiuchi M. Effect of transplantation of bone marrow-derived mesenchymal stem
cells on mice infected with prions. J Virol. 2009 Jun;83(11):5918-27. Epub 2009
Mar 18. PubMed PMID: 19297502; PubMed Central PMCID: PMC2681942.

Liu H, Koyanagi I, Chiba H, Wanibuchi M, Honmou O, Yamaki T, Houkin K. Spinal
cord infarct as the initial clinical presentation of intravascular malignant
lymphomatosis. J Clin Neurosci. 2009 Apr;16(4):570-3. Epub 2009 Feb 5. PubMed
PMID: 19200739.

Toyama K, Honmou O, Harada K, Suzuki J, Houkin K, Hamada H, Kocsis JD.
Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells
after cerebral ischemia. Exp Neurol. 2009 Mar;216(1):47-55. Epub 2008 Nov 27.
PubMed PMID: 19094989.

Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y,
Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H; TACT Follow-up Study Investigators. Long-term clinical outcome after
intramuscular implantation of bone marrow mononuclear cells (Therapeutic
Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb
ischemia. Am Heart J. 2008 Nov;156(5):1010-8. Epub 2008 Sep 19. PubMed PMID:
19061721.

Omori Y, Honmou O, Harada K, Suzuki J, Houkin K, Kocsis JD. Optimization of a
therapeutic protocol for intravenous injection of human mesenchymal stem cells
after cerebral ischemia in adult rats. Brain Res. 2008 Oct 21;1236:30-8. Epub
2008 Aug 9. PubMed PMID: 18722359; PubMed Central PMCID: PMC2605387.

Radtke C, Sasaki M, Lankford KL, Vogt PM, Kocsis JD. Potential of olfactory
ensheathing cells for cell-based therapy in spinal cord injury. J Rehabil Res
Dev. 2008;45(1):141-51. Review. PubMed PMID: 18566933.

Lankford KL, Sasaki M, Radtke C, Kocsis JD. Olfactory ensheathing cells
exhibit unique migratory, phagocytic, and myelinating properties in the
X-irradiated spinal cord not shared by Schwann cells. Glia. 2008 Nov
15;56(15):1664-78. PubMed PMID: 18551623.

Saito F, Nakatani T, Iwase M, Maeda Y, Hirakawa A, Murao Y, Suzuki Y, Onodera
R, Fukushima M, Ide C. Spinal cord injury treatment with intrathecal autologous
bone marrow stromal cell transplantation: the first clinical trial case report. J
Trauma. 2008 Jan;64(1):53-9. PubMed PMID: 18188099.

Marui A, Tabata Y, Kojima S, Yamamoto M, Tambara K, Nishina T, Saji Y, Inui
K, Hashida T, Yokoyama S, Onodera R, Ikeda T, Fukushima M, Komeda M. A novel
approach to therapeutic angiogenesis for patients with critical limb ischemia by
sustained release of basic fibroblast growth factor using biodegradable gelatin
hydrogel: an initial report of the phase I-IIa study. Circ J. 2007
Aug;71(8):1181-6. PubMed PMID: 17652878.

Onda T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Therapeutic
benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs
after cerebral ischemia. J Cereb Blood Flow Metab. 2008 Feb;28(2):329-40. Epub
2007 Jul 18. PubMed PMID: 17637706; PubMed Central PMCID: PMC2605394.

Sasaki M, Li B, Lankford KL, Radtke C, Kocsis JD. Remyelination of the
injured spinal cord. Prog Brain Res. 2007;161:419-33. Review. PubMed PMID:
17618995; PubMed Central PMCID: PMC2605400.

Honmou O, Houkin K. [A cell therapy for stroke]. Nihon Rinsho. 2006 Oct 28;64
Suppl 7:664-6. Review. Japanese. PubMed PMID: 17461219.

Radtke C, Spies M, Sasaki M, Vogt PM, Kocsis JD. Demyelinating diseases and
potential repair strategies. Int J Dev Neurosci. 2007 May;25(3):149-53. Epub 2007
Mar 3. Review. PubMed PMID: 17408905; PubMed Central PMCID: PMC2692731.

Ukai R, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Mesenchymal stem
cells derived from peripheral blood protects against ischemia. J Neurotrauma.
2007 Mar;24(3):508-20. PubMed PMID: 17402856; PubMed Central PMCID: PMC2605398.

Harada K, Honmou O, Liu H, Bando M, Houkin K, Kocsis JD. Magnetic resonance
lactate and lipid signals in rat brain after middle cerebral artery occlusion
model. Brain Res. 2007 Feb 23;1134(1):206-13. Epub 2006 Dec 29. PubMed PMID:
17196558; PubMed Central PMCID: PMC2605392.

Harada K, Honmou O, Odawara Y, Bando M, Houkin K. Optimization of
three-dimensional time-of-flight magnetic resonance angiography of the
intracranial arteries. Neurol Med Chir (Tokyo). 2006 Nov;46(11):523-8; discussion
528. PubMed PMID: 17124366.

Dombrowski MA, Sasaki M, Lankford KL, Kocsis JD, Radtke C. Myelination and
nodal formation of regenerated peripheral nerve fibers following transplantation
of acutely prepared olfactory ensheathing cells. Brain Res. 2006 Dec
13;1125(1):1-8. Epub 2006 Nov 16. PubMed PMID: 17112480; PubMed Central PMCID:
PMC2673087.

Kim S, Honmou O, Kato K, Nonaka T, Houkin K, Hamada H, Kocsis JD. Neural
differentiation potential of peripheral blood- and bone-marrow-derived precursor
cells. Brain Res. 2006 Dec 6;1123(1):27-33. Epub 2006 Oct 24. PubMed PMID:
17064670; PubMed Central PMCID: PMC2605382.

Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Intravenous
administration of glial cell line-derived neurotrophic factor gene-modified human
mesenchymal stem cells protects against injury in a cerebral ischemia model in
the adult rat. J Neurosci Res. 2006 Nov 15;84(7):1495-504. PubMed PMID: 16998918;
PubMed Central PMCID: PMC2605367.

Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H, Kocsis JD.
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral
ischaemia. Brain. 2006 Oct;129(Pt 10):2734-45. Epub 2006 Aug 10. PubMed PMID:
16901914; PubMed Central PMCID: PMC2605397.

Sasaki M, Black JA, Lankford KL, Tokuno HA, Waxman SG, Kocsis JD. Molecular
reconstruction of nodes of Ranvier after remyelination by transplanted olfactory
ensheathing cells in the demyelinated spinal cord. J Neurosci. 2006 Feb
8;26(6):1803-12. PubMed PMID: 16467529; PubMed Central PMCID: PMC2605396.

Sasaki M, Hains BC, Lankford KL, Waxman SG, Kocsis JD. Protection of
corticospinal tract neurons after dorsal spinal cord transection and engraftment
of olfactory ensheathing cells. Glia. 2006 Mar;53(4):352-9. PubMed PMID:
16288464; PubMed Central PMCID: PMC2605395.

Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. I.V. infusion of
brain-derived neurotrophic factor gene-modified human mesenchymal stem cells
protects against injury in a cerebral ischemia model in adult rat. Neuroscience.
2005;136(1):161-9. Epub 2005 Oct 17. PubMed PMID: 16229956; PubMed Central PMCID:
PMC2605391.

Kalanithi PS, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, Schwartz
ML, Leckman JF, Vaccarino FM. Altered parvalbumin-positive neuron distribution in
basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A.
2005 Sep 13;102(37):13307-12. Epub 2005 Aug 30. PubMed PMID: 16131542; PubMed
Central PMCID: PMC1201574.

Honma T, Honmou O, Iihoshi S, Harada K, Houkin K, Hamada H, Kocsis JD.
Intravenous infusion of immortalized human mesenchymal stem cells protects
against injury in a cerebral ischemia model in adult rat. Exp Neurol. 2006
May;199(1):56-66. Epub 2005 Jun 20. PubMed PMID: 15967439; PubMed Central PMCID:
PMC2605388.

Hamada H, Kobune M, Nakamura K, Kawano Y, Kato K, Honmou O, Houkin K,
Matsunaga T, Niitsu Y. Mesenchymal stem cells (MSC) as therapeutic cytoreagents
for gene therapy. Cancer Sci. 2005 Mar;96(3):149-56. Review. PubMed PMID:
15771617.

Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M, Hirai S,
Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H.
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage
in the rat middle cerebral artery occlusion model. Mol Ther. 2005
Jan;11(1):96-104. PubMed PMID: 15585410.

Oka S, Honmou O, Akiyama Y, Sasaki M, Houkin K, Hashi K, Kocsis JD.
Autologous transplantation of expanded neural precursor cells into the
demyelinated monkey spinal cord. Brain Res. 2004 Dec 24;1030(1):94-102. PubMed
PMID: 15567341.

Sasaki M, Lankford KL, Zemedkun M, Kocsis JD. Identified olfactory
ensheathing cells transplanted into the transected dorsal funiculus bridge the
lesion and form myelin. J Neurosci. 2004 Sep 29;24(39):8485-93. PubMed PMID:
15456822; PubMed Central PMCID: PMC2605369.

Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou
O, Niitsu Y, Hamada H. Antitumor effect of genetically engineered mesenchymal
stem cells in a rat glioma model. Gene Ther. 2004 Jul;11(14):1155-64. PubMed
PMID: 15141157.

Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD. A therapeutic window for
intravenous administration of autologous bone marrow after cerebral ischemia in
adult rats. Brain Res. 2004 May 8;1007(1-2):1-9. PubMed PMID: 15064130.

Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, Uchida H,
Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H. BDNF gene-modified
mesenchymal stem cells promote functional recovery and reduce infarct size in the
rat middle cerebral artery occlusion model. Mol Ther. 2004 Feb;9(2):189-97.
Erratum in: Mol Ther. 2004 May;9(5):766. PubMed PMID: 14759803.

Inoue M, Honmou O, Oka S, Houkin K, Hashi K, Kocsis JD. Comparative analysis
of remyelinating potential of focal and intravenous administration of autologous
bone marrow cells into the rat demyelinated spinal cord. Glia. 2003
Nov;44(2):111-8. PubMed PMID: 14515327; PubMed Central PMCID: PMC2605389.

Kobune M, Kawano Y, Ito Y, Chiba H, Nakamura K, Tsuda H, Sasaki K, Dehari H,
Uchida H, Honmou O, Takahashi S, Bizen A, Takimoto R, Matsunaga T, Kato J, Kato
K, Houkin K, Niitsu Y, Hamada H. Telomerized human multipotent mesenchymal cells
can differentiate into hematopoietic and cobblestone area-supporting cells. Exp
Hematol. 2003 Aug;31(8):715-22. PubMed PMID: 12901977.

Tanaka H, Hata F, Nishimori H, Honmou O, Yasoshima T, Nomura H, Ohno K, Hirai
I, Kamiguchi K, Isomura H, Hirohashi Y, Denno R, Sato N, Hirata K. Differential
gene expression screening between parental and highly metastatic pancreatic
cancer variants using a DNA microarray. J Exp Clin Cancer Res. 2003
Jun;22(2):307-13. PubMed PMID: 12866582.

Akiyama Y, Radtke C, Honmou O, Kocsis JD. Remyelination of the spinal cord
following intravenous delivery of bone marrow cells. Glia. 2002 Sep;39(3):229-36.
PubMed PMID: 12203389; PubMed Central PMCID: PMC2605380.

Lankford KL, Imaizumi T, Honmou O, Kocsis JD. A quantitative morphometric
analysis of rat spinal cord remyelination following transplantation of allogenic
Schwann cells. J Comp Neurol. 2002 Feb 11;443(3):259-74. PubMed PMID: 11807836;
PubMed Central PMCID: PMC2605379.

Sasaki M, Honmou O, Akiyama Y, Uede T, Hashi K, Kocsis JD. Transplantation of
an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal
cord axons. Glia. 2001 Jul;35(1):26-34. PubMed PMID: 11424189; PubMed Central
PMCID: PMC2605363.